# Max Planck Society

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/max-planck-society/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 57.2 |
| Citations | 21,443,739 |
| City | Munich |
| Country | DE |
| Description | Max Planck Society is a research organisation in Munich, DE. OpenAlex records 292,166 works and 21,443,739 citations for it. 25,216 researchers list it as their most recent affiliation. |
| Homepage | http://www.mpg.de/en |
| OpenAlex ID | https://openalex.org/I149899117 |
| Region | Bavaria |
| Researchers | 25,216 |
| ROR ID | https://ror.org/01hhn8329 |
| Type | nonprofit |
| Works | 292,166 |

## University papers

Showing 12 of 34.

- [<i>Gaia</i> Data Release 2](https://scholariq.org/papers/i-gaia-i-data-release-2/)
- [The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)](https://scholariq.org/papers/the-multimodal-brain-tumor-image-segmentation-benchmark-brats/)
- [Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis](https://scholariq.org/papers/pathological-complete-response-and-long-term-clinical-benefit-in-breast-cancer/)
- [Heuristic Decision Making](https://scholariq.org/papers/heuristic-decision-making/)
- [Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013](https://scholariq.org/papers/personalizing-the-treatment-of-women-with-early-breast-cancer-highlights-of-the/)
- [The ATLAS Experiment at the CERN Large Hadron Collider](https://scholariq.org/papers/the-atlas-experiment-at-the-cern-large-hadron-collider/)
- [Helping Doctors and Patients Make Sense of Health Statistics](https://scholariq.org/papers/helping-doctors-and-patients-make-sense-of-health-statistics/)
- [Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort](https://scholariq.org/papers/neoadjuvant-chemotherapy-with-trastuzumab-followed-by-adjuvant-trastuzumab/)
- [De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017](https://scholariq.org/papers/de-escalating-and-escalating-treatments-for-early-stage-breast-cancer-the-st/)
- [Symbol Nomenclature for Graphical Representations of Glycans](https://scholariq.org/papers/symbol-nomenclature-for-graphical-representations-of-glycans/)
- [Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/pertuzumab-trastuzumab-and-docetaxel-for-her2-positive-metastatic-breast-cancer/)
- [The priority heuristic: Making choices without trade-offs.](https://scholariq.org/papers/the-priority-heuristic-making-choices-without-trade-offs/)

## University researchers

- [Iris Knierim](https://scholariq.org/researchers/iris-knierim/)

## University top topics

Showing 8 of 22.

- [Magnetic confinement fusion research](https://scholariq.org/topics/magnetic-confinement-fusion-research/)
- [Ionosphere and magnetosphere dynamics](https://scholariq.org/topics/ionosphere-and-magnetosphere-dynamics/)
- [Solar and Space Plasma Dynamics](https://scholariq.org/topics/solar-and-space-plasma-dynamics/)
- [Fusion materials and technologies](https://scholariq.org/topics/fusion-materials-and-technologies/)
- [Stellar, planetary, and galactic studies](https://scholariq.org/topics/stellar-planetary-and-galactic-studies/)
- [Astro and Planetary Science](https://scholariq.org/topics/astro-and-planetary-science/)
- [Particle accelerators and beam dynamics](https://scholariq.org/topics/particle-accelerators-and-beam-dynamics/)
- [Galaxies: Formation, Evolution, Phenomena](https://scholariq.org/topics/galaxies-formation-evolution-phenomena/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.